Join Growin Stock Community!

Penumbra, inc.PEN.US Overview

US StockHealthcare
(No presentation for PEN)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

PEN AI Insights

PEN Overall Performance

PEN AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

PEN Recent Performance

-0.91%

Penumbra, inc.

0.05%

Avg of Sector

-0.31%

S&P500

PEN PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

PEN Key Information

PEN Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

PEN Profile

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Price of PEN

PEN FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

PEN Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
4.53
PE Ratio (TTM)
-
Forward PE
70.07
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
76.76
METRIC
VALUE
vs. INDUSTRY
Gross Margin
67.14%
Net Margin
12.66%
Revenue Growth (YoY)
17.50%
Profit Growth (YoY)
24.83%
3-Year Revenue Growth
20.33%
3-Year Profit Growth
23.72%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
4.53
PE Ratio (TTM)
-
Forward PE
70.07
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
76.76
Gross Margin
67.14%
Net Margin
12.66%
Revenue Growth (YoY)
17.50%
Profit Growth (YoY)
24.83%
3-Year Revenue Growth
20.33%
3-Year Profit Growth
23.72%

  • When is PEN's latest earnings report released?

    The most recent financial report for Penumbra, inc. (PEN) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating PEN's short-term business performance and financial health. For the latest updates on PEN's earnings releases, visit this page regularly.

  • Where does PEN fall in the P/E River chart?

    According to historical valuation range analysis, Penumbra, inc. (PEN)'s current price-to-earnings (P/E) ratio is 64.34, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of PEN?

    According to the latest financial report, Penumbra, inc. (PEN) reported an Operating Profit of 59.23M with an Operating Margin of 15.37% this period, representing a growth of 38.48% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is PEN's revenue growth?

    In the latest financial report, Penumbra, inc. (PEN) announced revenue of 385.39M, with a Year-Over-Year growth rate of 22.14%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does PEN have?

    As of the end of the reporting period, Penumbra, inc. (PEN) had total debt of 219.7M, with a debt ratio of 0.12. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does PEN have?

    At the end of the period, Penumbra, inc. (PEN) held Total Cash and Cash Equivalents of 186.9M, accounting for 0.1 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does PEN go with three margins increasing?

    In the latest report, Penumbra, inc. (PEN) achieved the “three margins increasing” benchmark, with a gross margin of 68.02%%, operating margin of 15.37%%, and net margin of 12.28%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess PEN's profit trajectory and future growth potential.

  • Is PEN's EPS continuing to grow?

    According to the past four quarterly reports, Penumbra, inc. (PEN)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 1.21. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of PEN?

    Penumbra, inc. (PEN)'s Free Cash Flow (FCF) for the period is 68.05M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 48.79% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of PEN?

    The latest valuation data shows Penumbra, inc. (PEN) has a Price-To-Earnings (PE) ratio of 64.34 and a Price/Earnings-To-Growth (PEG) ratio of 18.82. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.